A Limitation of 2-Stage Serological Testing for Lyme Disease: Enzyme Immunoassay and Immunoblot Assay Are Not Independent Tests
Open Access
- 1 March 2000
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 30 (3) , 545-548
- https://doi.org/10.1086/313688
Abstract
To improve the accuracy of testing for antibody to Borrelia burgdorferi, 2-stage conditional testing has been recommended, in which sera that yield pKeywords
This publication has 10 references indexed in Scilit:
- False-Positive HIV-1 Test Results in a Low-Risk Screening Setting of Voluntary Blood DonationJAMA, 1998
- Hepatitis CThe Lancet, 1998
- Laboratory Evaluation in the Diagnosis of Lyme DiseaseAnnals of Internal Medicine, 1997
- Guidelines for Laboratory Evaluation in the Diagnosis of Lyme DiseaseAnnals of Internal Medicine, 1997
- Accuracy of IgM Immunoblotting to Confirm the Clinical Diagnosis of Early Lyme DiseaseArchives of internal medicine (1960), 1996
- Serological follow-up after treatment of patients with erythema migrans and neuroborreliosisJournal of Clinical Microbiology, 1994
- Serodiagnosis in early Lyme diseaseJournal of Clinical Microbiology, 1993
- Persistence of Serum Antibodies to Borrelia burgdorferi in Patients Treated for Lyme DiseaseClinical Infectious Diseases, 1992